Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20181217005
TCTR20181217005
Enrolling By Invitation
Phase 1

Movement therapy in patients with temporomandibular disorder and scapulocostal syndrome

no0 sites64 target enrollmentDecember 17, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsThe TMD patients selected on myofascial type (Axis I&#44group I)&#44clicking without joint pain with SCS age between 18 to 50 yearstemporomandibular disorder&#44scapulocostal syndrome&#44movement therapy&#44myofascial linkage

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
The TMD patients selected on myofascial type (Axis I&#44
Sponsor
no
Enrollment
64
Status
Enrolling By Invitation
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2018
End Date
November 1, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
no

Eligibility Criteria

Inclusion Criteria

  • •1\.Female and male age between 18 to 50 years
  • •2\.Present pain at masticatory muscles at least 1 point
  • •3\.Present with moderate pain (VAS score more than 3\)
  • •4\.Present pain\-free mouth opening less than 40 mm
  • •5\.Present TMD longer than 3 months
  • •6\.Patients must the 1st and the 2nd premolar teeth
  • •7\.Able to follow the instructions
  • •8\.Good consciousness and co\-operation

Exclusion Criteria

  • •1\.TMD with disc displacement and osteoarthritis (Axis I,
  • •group II, and group III)
  • •2\.A history of the following diseases or disorders
  • •\- Other type of headache including migraine with aura,
  • •tension type headache with central sensitization, and cervicogenic headache.
  • •\- Systemic disease including cardiovascular, pulmonary,
  • •gastrointestinal, urogenital, endocrine, nervous system, and integumentary disease.
  • •\- Serious condition including accident, spinal fractures,
  • •spinal or central cord compression, neoplastic, vascular compromise, system or inflammatory diseases, and upper cervical spine ligamentous instability
  • •3\.Unable to follow the instructions

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Intra-oral myofascial therapy compared to education and self care for chronic myogenous temporomandibular disorder. A randomised trial
ACTRN12610000508077Macquarie University60
Completed
Not Applicable
Motorised Movement Therapy in Non-ambulant Adults with Cerebral Palsy: A pilot study utilizing the MOTOmed.Cerebral PalsyNon-ambulantNeurological - Other neurological disordersMusculoskeletal - Other muscular and skeletal disordersPhysical Medicine / Rehabilitation - Physiotherapy
ACTRN12623000242628St. Vincent's Hospital Melbourne10
Recruiting
Not Applicable
Motorized Movement Therapy in Non-ambulant Adults with Cerebral Palsy: A pilot study investigating Cardiometabolic Biomarkers, Health and Wellbeing Outcomes.Cerebral palsyNon-ambulantNeurological - Other neurological disordersMusculoskeletal - Other muscular and skeletal disordersPhysical Medicine / Rehabilitation - PhysiotherapyCardiovascular - Other cardiovascular diseases
ACTRN12623000954628St. Vincent's Hospital Melbourne25
Completed
Not Applicable
eck rehabilitation in subjects with temporomandibular pain. A randomized controlled clinical trial
RBR-6c7rq4niversidade Federal de São Carlos- UFSCar
Recruiting
Phase 1
Treatment of TMJ disorder using autologous ADSCs (AUASC-TKY2017)Refractory emporomandibular joint disorder with the symptoms of osteoarthritis (pain and/or trismus)
JPRN-jRCTb030190134Hoshi Kazuto3